Skip to search formSkip to main contentSkip to account menu

pegvisomant

Known as: Growth hormone, Somatotropin (18-Aspartic Acid, 21-Asparagine, 120-Lysine, 167-Asparagine, 168-Alanine, 171-Serine, 172-Arginine, 174-Serine, 179-Threonine) (Human), Pegylated, Somatotropin precursor 
A pegylated, recombinant, human growth hormone (GH) structural analog with GH receptor antagonist activity. As a GH analog, the structure of… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1995
Highly Cited
1995
Zinc depletion attenuates growth and decreases circulating IGF-I. To investigate the mechanisms responsible for the IGF-I decline… 
Highly Cited
1993
Highly Cited
1993
Neuropeptide Y (NPY) has been recently characterized in the goldfish and the sequence deduced from goldfish brain cDNA clones… 
Highly Cited
1985
Highly Cited
1985
Human GH-releasing hormone [hGHRH-40 (GHRH)] stimulates GH release in a dose-dependent fashion when administered as single iv… 
Highly Cited
1984
Highly Cited
1984
After initial challenges with vehicle alone and then 10 micrograms/kg human pancreatic tumor GH-releasing factor (hpGRF)-40, six… 
Highly Cited
1981
Highly Cited
1981
The role of endogenous opioid receptors on anterior pituitary hormone secretion was evaluated by the administration of the opioid… 
Highly Cited
1977
Highly Cited
1977
The serum levels of thyrotrophin (TSH), prolactin (PRL) and growth hormone (GH) and the response of these hormones to 500 mug… 
Highly Cited
1976
Highly Cited
1976
The effect of thyrotrophin-releasing hormone (TRH) or luteinizing hormone-releasing hormone (LH-RH) on plasma levels of growth… 
Highly Cited
1976
Highly Cited
1976
The new mouse mutation little (lit) in the homozygous state causes a pituitary deficiency involving at least growth hormone (GH…